drugset / Trial / NCT00213109

Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment

NCT00213109 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Miglitol Small molecule — —